Literature DB >> 30070692

Deletion of Axin1 in condylar chondrocytes leads to osteoarthritis-like phenotype in temporomandibular joint via activation of β-catenin and FGF signaling.

Yachuan Zhou1,2, Bing Shu3, Rong Xie2, Jian Huang2, Liwei Zheng1, Xuedong Zhou1, Guozhi Xiao2,4, Lan Zhao2, Di Chen2.   

Abstract

Osteoarthritis (OA) in the temporomandibular joint (TMJ) is a degenerative disease in the adult, which is characterized by the pathological degeneration of condylar cartilage. Axin1 plays a critical role in the regulation of cartilage development and homeostasis. To determine the role of Axin1 in TMJ tissue at the adult stage, we generated Axin1Agc1ER mice, in which Axin1 was deleted in aggrecan-expressing chondrocytes at 2 months of age. Histology, histomorphometry, and immunostaining analyses were performed using TMJ tissues harvested from 4- and 6-month-old mice after tamoxifen administration. Total RNA isolated from TMJ cartilage of 6-month-old mice was used for gene expression analysis. Progressive OA-like degeneration was observed in condylar cartilage in Axin1 knockout (KO) mice with loss of surface continuity and the formation of vertical fissures. In addition, reduced alcian blue staining in condylar cartilage was also found in Axin1 KO mice. Immunostaining and reverse transcription quantitative polymerase chain reaction (qRT-PCR) assays revealed disturbed homeostasis in condylar cartilage with increased expressions of MMP13 and Adamts5 and decreased lubricin expression in Axin1-deficient chondrocytes. Less proliferative cells with increased hypertrophic and apoptotic activities were presented in the condylar cartilage of Axin1Agc1ER KO mice. As a scaffolding protein, the deletion of Axin1 stimulated not only the β-catenin but also the fibroblast growth factor (FGF) signaling via extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) activation. The qRT-PCR results showed an increased expression of Fgfr1 in Axin1 KO cartilage. Overall, the deletion of Axin1 in condylar chondrocytes altered the β-catenin and FGF/ERK1/2 signaling pathways, thus cooperatively contribute to the cartilage degeneration.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  axis inhibition protein (axin1); fibroblast growth factor (FGF)/ERK; osteoarthritis (OA); temporomandibular joint (TMJ); β-catenin

Mesh:

Substances:

Year:  2018        PMID: 30070692      PMCID: PMC6246803          DOI: 10.1002/jcp.27043

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  37 in total

1.  The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development.

Authors:  Takamitsu Maruyama; Anthony J Mirando; Chu-Xia Deng; Wei Hsu
Journal:  Sci Signal       Date:  2010-05-25       Impact factor: 8.192

2.  Muenke syndrome mutation, FgfR3P²⁴⁴R, causes TMJ defects.

Authors:  T Yasuda; H D Nah; J Laurita; T Kinumatsu; Y Shibukawa; T Shibutani; N Minugh-Purvis; M Pacifici; E Koyama
Journal:  J Dent Res       Date:  2012-05-23       Impact factor: 6.116

3.  Activation of β-catenin signalling leads to temporomandibular joint defects.

Authors:  M Wang; S Li; W Xie; J Shen; H J Im; J D Holz; M Wang; T G Diekwisch; D Chen
Journal:  Eur Cell Mater       Date:  2014-10-23       Impact factor: 3.942

4.  Generation of Axin1 conditional mutant mice.

Authors:  Rong Xie; Rulang Jiang; Di Chen
Journal:  Genesis       Date:  2011-02       Impact factor: 2.487

5.  Mouse axin and axin2/conductin proteins are functionally equivalent in vivo.

Authors:  Ian V Chia; Frank Costantini
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

Review 6.  Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis.

Authors:  Michael B Ellman; Howard S An; Prasuna Muddasani; Hee-Jeong Im
Journal:  Gene       Date:  2008-05-09       Impact factor: 3.688

7.  Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice.

Authors:  Mei Zhu; Dezhi Tang; Qiuqian Wu; Suyang Hao; Mo Chen; Chao Xie; Randy N Rosier; Regis J O'Keefe; Michael Zuscik; Di Chen
Journal:  J Bone Miner Res       Date:  2009-01       Impact factor: 6.741

8.  Both the RGS domain and the six C-terminal amino acids of mouse Axin are required for normal embryogenesis.

Authors:  Ian V Chia; Min Jung Kim; Keiji Itoh; Sergei Y Sokol; Frank Costantini
Journal:  Genetics       Date:  2009-02-09       Impact factor: 4.562

Review 9.  The Regulatory Role of Signaling Crosstalk in Hypertrophy of MSCs and Human Articular Chondrocytes.

Authors:  Leilei Zhong; Xiaobin Huang; Marcel Karperien; Janine N Post
Journal:  Int J Mol Sci       Date:  2015-08-14       Impact factor: 5.923

10.  CHIP regulates bone mass by targeting multiple TRAF family members in bone marrow stromal cells.

Authors:  Tingyu Wang; Shan Li; Dan Yi; Guang-Qian Zhou; Zhijie Chang; Peter X Ma; Guozhi Xiao; Di Chen
Journal:  Bone Res       Date:  2018-03-29       Impact factor: 13.567

View more
  4 in total

1.  A novel approach to establishing a temporomandibular joint fibrocartilage cell line.

Authors:  Yusen Qiao; Dan Yi; David Andrew Reed; Louis G Mercuri; Di Chen; Chun-do Oh
Journal:  J Dent Sci       Date:  2022-05-12       Impact factor: 3.719

Review 2.  Animal Models of Temporomandibular Joint Osteoarthritis: Classification and Selection.

Authors:  Yuqing Zhao; Yanxin An; Libo Zhou; Fan Wu; Gaoyi Wu; Jing Wang; Lei Chen
Journal:  Front Physiol       Date:  2022-04-28       Impact factor: 4.755

Review 3.  Molecular signaling in temporomandibular joint osteoarthritis.

Authors:  Ke Lu; Feng Ma; Dan Yi; Huan Yu; Liping Tong; Di Chen
Journal:  J Orthop Translat       Date:  2021-09-10       Impact factor: 4.889

4.  Changes in DNA methylation accompany changes in gene expression during chondrocyte hypertrophic differentiation in vitro.

Authors:  Purva Singh; Samantha G Lessard; Piali Mukherjee; Brennan Rourke; Miguel Otero
Journal:  Ann N Y Acad Sci       Date:  2020-09-25       Impact factor: 5.691

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.